NRC Health
corporate_fare Company Profile
NRC Health (NASDAQ:NRC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for NRC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for NRC spans 8-K, 10-Q, SCHEDULE 13D/A, 424B7.
Recent high-impact activity:
- NRC Health CFO Shane Harrison Steps Down; Successor Search Begins
- NRC Health Q2 2026: Operating Loss on Surging Stock Comp, Revenue Up 4%
- NRC Health Q2: GAAP Loss Widens on Executive Comp Charges, but Adjusted EBITDA Holds at 27% Margin
- NRC Health Finalizes Major Corporate Governance Reforms
- Founder-Related Trusts Sell $5M in NRC Health Stock; Chairman's Direct Stake Drops Below 5%
Financial Snapshot
Short Interest & Short Volume
5.93 days to coverFINRA reported short interest of 685,377 shares in NRC as of the September 15, 2026 settlement, a 7.7% increase from the prior period — about 5.9 days to cover at its recent average daily volume. On October 2, 2026, 91.2% of NRC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NRC, detected from its recent SEC filings · based on capital-structure filings through 2026-05-13.
Massive Share Offering Registered · Significant Market Overhang
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →